Wave life sciences announces continued momentum in gsk collaboration and advancements in sirna and rna editing

Gsk has selected the first two programs to advance following achievement of target validation, marking transition to next phase of research collaboration; programs utilize wave's next generation galnac-sirna format with potential for best-in-class potency and durability

WVE Ratings Summary

WVE Quant Ranking